•   Ken D’Andrea, Chairman of Zachriel Neurosciences Foundation

Ken brings a rare combination of healthcare operations, civic leadership, nonprofit service, and community trust to ZN’s mission. Public sources identify him as Vice President of Contact Centers at MedStar Health, a former Evesham Township Councilman and Deputy Mayor, President of the Evesham Celebrations Foundation, Commissioner of Marlton Soccer, and Treasurer of the Marlton Recreation Council. His background gives ZN Foundation practical leadership in healthcare communication, public accountability, volunteer coordination, donor outreach, community engagement, and sponsor relationship-building

 

As Chairman, Ken helps carry forward the Alzheimer’s research legacy of his brother, Dr. Michael D’Andrea, while strengthening ZN Foundation’s ability to organize a serious nonprofit funding campaign for the independent CRO-run human study. His experience in healthcare operations, municipal leadership, and nonprofit community service helps sponsors see that ZN is guided not only by scientific and medical advisors, but also by a chairman with practical experience building teams, earning public trust, and moving mission-driven initiatives from concept to action.

 

•   Alfred "Al" R. Pierce Jr.  - President / CEO, Zachriel Neurosciences Foundation

Alfred “Al” R. Pierce Jr. brings entrepreneurial, invention, product-development, fundraising, and operating experience to Zachriel Neurosciences. As President / CEO, he helps drive the organization’s mission to advance Dr. Michael D’Andrea’s Alzheimer’s and MCI discoveries into a practical independent CRO-run human study, while coordinating sponsor outreach, advisory input, nonprofit fundraising, and execution planning.

 

His leadership role strengthens sponsor confidence because ZN’s next milestone requires more than scientific promise; it requires practical organization, persistence, team coordination, donor communication, and operational follow-through. Mr. Pierce helps connect Dr. D’Andrea’s scientific legacy, ZN’s patent-pending treatment approach, the nonprofit funding campaign, and the independent study plan into a focused initiative sponsors can understand and support.

 

•  Dr. Matthew Philips, MD - Medical Advisor

Dr. Matthew Philips, MD brings high-level neurological and clinical credibility to ZN Foundation as a board-certified neurosurgeon and Chief of Brain & Spine Services at Southcoast Health. A Yale School of Medicine graduate who completed his neurosurgery residency at the University of Pennsylvania and fellowship training in complex and reconstructive spinal surgery, Dr. Philips adds deep medical judgment to the Advisory Board, including experience involving brain, spine, trauma, tumors, epilepsy, and patient-safety considerations.

 

For sponsors, Dr. Philips helps show that the proposed independent CRO-run human study is being reviewed with serious clinical discipline rather than organizational enthusiasm alone. His neurosurgical background supports responsible medical review, patient-centered evaluation, and sponsor confidence as ZN Foundation advances an individualized treatment approach for MCI and early Alzheimer’s disease.

​

•  Dr. Neal Naito MD, MPH - Chief Medical Officer

Dr. Neal Naito, MD, MPH strengthens the Team through a rare combination of medical, public-health, military, biotech, and strategic leadership experience. Public profiles describe him as a physician and public-health leader, a former U.S. Navy Medical Corps Captain, and a biotech entrepreneur with experience in medical innovation, drug research and development, healthcare delivery, policy development, and strategic planning.

For sponsors, Dr. Naito’s relevance is the scientific and public-health discipline he brings to the proposed study. His background supports the responsible evaluation of ZN’s treatment rationale, biomarker strategy, clinical interpretation, and broader health-impact potential, helping sponsors understand that the study is being guided by experienced advisors with both scientific and real-world healthcare perspective.

​

•  Dr. Barry M. Fabius - Medical Advisor

Dr. Barry M. Fabius, MD adds important geriatric, internal medicine, and healthcare leadership experience to the ZN Team. With more than 40 years of medical experience, a University of Pennsylvania undergraduate background, Temple University medical training, and healthcare leadership experience connected to UnitedHealthcare, Dr. Fabius brings a practical senior-care and real-world patient-outcomes perspective to the proposed independent human study.​

​

His role is especially relevant because MCI and Alzheimer’s disease primarily affect older adults, families, caregivers, senior-care providers, and healthcare payers. For sponsors, Dr. Fabius helps demonstrate that ZN Foundation is considering not only the science behind the treatment, but also the patientcare, caregiver, payer-system, and aging-health realities that shape Alzheimer’s care.

​

• ​ Nicholas "Nick" W. Moss - Business Advisor

Nicholas “Nick” W. Moss brings seasoned public-company business and operating experience to the ZN Advisory Board. As a former senior executive with Mueller Industries, including leadership roles publicly listed as President of Retail Business and President of B&K LLC, he adds practical guidance on operations, resource planning, execution discipline, business development, and sponsor-readiness.

​

For sponsors, Mr. Moss helps show that ZN is supported not only by medical and scientific advisors, but also by experienced business leadership. His practical operating background is valuable as ZN coordinates advisors, donors, sponsors, CRO planning, funding strategy, and the disciplined execution required to move a promising scientific opportunity into an independent human-study process.

​

•   William W. Uchimoto, Esq - Business Advisor

William W. Uchimoto, Esq. brings more than four decades of corporate, securities, regulatory, compliance, and capital-markets experience to the ZN Team. As former Senior Vice President and General Counsel of the Philadelphia Stock Exchange and a former attorney with the U.S. SEC Division of Market Regulation, he adds sophisticated legal and governance perspective to ZN’s funding-readiness strategy.

 

His advisory role is important because ZN has both a charitable nonprofit sponsorship path and a separate for-profit investment path through Zachriel Neurosciences LLC. For sponsors and potential investors, Mr. Uchimoto helps strengthen confidence in governance, disclosure discipline, separation of charitable and securities-related communications, and the overall professionalism of ZN’s organizational structure.

​

• Dr. Michael R. D'Andrea, PhD - Scientific Founder / Discovery Foundation

Dr. Michael R. D’Andrea’s scientific work forms the foundation for ZN’s patent-pending individualized treatment approach for MCI and Alzheimer’s disease. ZN materials describe him as a scientist with more than 100 scientific publications, more than 200 abstracts, more than 30 national and international presentations, two Alzheimer’s-related books, and involvement in more than 11 scientific patents, with prior experience as a Principal Scientist at Johnson & Johnson Pharmaceutical Research & Development.

 

For sponsors, Dr. D’Andrea’s legacy provides the scientific reason this independent study matters. His work challenged one-size-fits-all Alzheimer’s treatment thinking and focused on earlier, multi-targeted intervention, including the proprietary repurposing of existing FDA-approved generic medications within an individualized treatment concept that now requires independent human evaluation.

​

​

• Linda Arnold - Sponsorship Director

As a professional fundraising consultant and Development Director, Linda is dedicated to building meaningful partnerships that generate sustainable support for life-changing initiatives. She has extensive experience working with individual donors, foundations, corporations, and community leaders to develop strategic fundraising programs that strengthen organizational impact and long-term growth.

​

At Zachriel Neurosciences, Linda is committed to expanding philanthropic support that accelerates groundbreaking neuroscience research, education, and patient advocacy. She believes that collaboration, transparency, and innovation are the cornerstones of successful development efforts and works to create lasting relationships that empower donors to make a meaningful difference. Driven by a commitment to service and social impact, Linda is passionate about helping organizations transform vision into reality by securing the resources needed to advance their mission and improve lives.

​

•